Are nucleot(s)ide analogues a negative factor for HBsAg seroconversion in acute hepatitis B?

M F Keser1, M A Erdogan2, O Yıldırım2

  • 1Battalgazi State Hospital, Internal Medicine Clinic, Malatya, Turkey.

PubMed
Summary

Tenofovir disoproxil fumarate (TDF) therapy in acute hepatitis B may increase chronicity rates and reduce natural immunity development. Further research is needed to confirm these findings for antiviral treatment efficacy.